Skip to main content

Join us Feb. 13 at 11 a.m. ET for “Breaking Barriers with Digital Health Technologies,” unveiling new resources to advance CRS risk prediction and support DHT development. Don’t miss it!

Take the fast track to becoming a V3 and V3+ expert

EMA V3

“New DHT tools can help move the field of CNS drug development forward, but their disruptive potential can only be realized through coordinated and early interactions between all the stakeholders.” — Mantua, et al.